Company Description
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally.
It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.
The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints.
In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions.
Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems.
The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
| Country | United Kingdom |
| Founded | 1856 |
| IPO Date | Nov 16, 1999 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 19,081 |
| CEO | Deepak Nath |
Contact Details
Address: Building 5, Croxley Park Watford, WD18 8YE United Kingdom | |
| Phone | 44 1923 477 100 |
| Website | smith-nephew.com |
Stock Details
| Ticker Symbol | SNN |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000845982 |
| CUSIP Number | 83175M205 |
| ISIN Number | US83175M2052 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Dr. Deepak S. Nath Ph.D. | Chief Executive Officer and Director |
| John Terence Rogers | Chief Financial Officer and Executive Director |
| Paul Connolly | President of Global Operations |
| Andrew Swift | Vice President of Investor Relations |
| Helen Barraclough | Group General Counsel and Company Secretary |
| Alison Parkes | Chief Compliance Officer and Compliance APAC |
| Joe Metzger | Senior Vice President of Marketing Services and Communications |
| Philip G. Cowdy | Chief Corporate Development and Corporate Affairs Officer |
| Elga Lohler | Chief Human Resources Officer |
| Dr. Vasant Padmanabhan Ph.D. | President of Research and Development and Ear, Nose & Throat |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 12, 2024 | 6-K | Report of foreign issuer |
| Nov 12, 2024 | 6-K | Report of foreign issuer |
| Nov 1, 2024 | 6-K | Report of foreign issuer |
| Nov 1, 2024 | 6-K | Report of foreign issuer |
| Oct 31, 2024 | 6-K | Report of foreign issuer |
| Oct 31, 2024 | 6-K | Report of foreign issuer |
| Oct 24, 2024 | 6-K | Report of foreign issuer |
| Oct 16, 2024 | 6-K | Report of foreign issuer |
| Oct 1, 2024 | 6-K | Report of foreign issuer |
| Sep 27, 2024 | 6-K | Report of foreign issuer |